retatrutide clinical trial A New Obesity Drug Delivered Surgery-Level Weight Loss in Trials Trial of next-gen weight-loss drug

Alcohol compounds this, raising the risk of kidney-related complications

What the courts decide in this matter will affect the future of many plaintiffs in the Trulicity litigation

Maybe your original day no longer works with your schedule

A MWL APPOINTMENT AT LUXX When you come to Luxx for medical weight loss injections, each appointment follows the same formula

Retatrutide (LY3437943) is blowing up both the pharmaceutical world and the bodybuilding world for the same reason: This triple G multi-receptor agonist manufactured by pharmaceutical company Eli Lilly has paved the way for what could be an entirely new generation of anti-obesity drugs

Research on other GLP-1 agonists like Semaglutide has consistently shown that women report greater reduction in food cravings and portion sizes compared to men at equivalent doses